TC
KDNY

TFS Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

TFS Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,000
Closed -$194K – 944
2015
Q3 		$194K Buy
+2,000
New +$238K 0.02% 743

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

TFS Capital's KDNY Position: Q4 2015 in Review

TFS Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2015, closing a stake of 2,000 shares — an estimated $194K sold.

TFS Capital first reported a position in KDNY in Q3 2015 and held it in 1 quarter. The position peaked at $194K in Q3 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2015.

  • TFS Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 2,000 Chinook Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $194K.
  • TFS Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • TFS Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $194K in Q3 2015.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.